Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase
(NASDAQ:IINN), RA'ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. […]